Scientific Platform Sessions
Scientific Platform Sessions
Tuesday, April 25
Monday 3:30 p.m.–5:30 p.m.
Monday 3:30 p.m.–5:30 p.m.
Tuesday 8:00 a.m.–9:00 a.m.
Tuesday 1:00 p.m.–3:00 p.m.
S17 Movement Disorders: Ataxia
S18 Behavioral and Cognitive
S19 “Best of” Session:
S20 Neuromyelitis Optica
3:30 p.m.
3:30 p.m. Norman Geschwind Prize in
Titles and authors of these abstracts
1:00 p.m.
S20.001
1:12 p.m.
S20.002
1:24 p.m.
S20.003
1:36 p.m.
S20.004
1:48 p.m.
S20.005
2:00 p.m.
S20.006
2:12 p.m.
S20.007
2:24 p.m.
S20.008
2:36 p.m.
Discussion
and the Cerebellum S17.001
ATXN2 antisense therapy improves SCA2 mouse motor and Purkinje cell electrophysiological phenotypes. —Daniel Scoles, Matthew Schneider, Pratap Meera, Karla Figueroa, Frank Rigo, Frank Bennett, Thomas Otis, Stefan Pulst
3:42 p.m.
S17.002
Fragile X Gray Zone Alleles are associated with Better Global Motor Function in an Elderly Community Population —Deborah Hall, Aisha Ali, David Bennett, Bichum Ouyang, Aron Buchman, Lili Zhou, Elizabeth Berry-Kravis
3:54 p.m.
S17.003
RT001 First-in Human Clinical Trial Demonstrates Safety, Favorable Pharmacokinetics, and Early Signals of Efficacy in Friedreich’s Ataxia —Theresa Zesiewicz, Frederic Heerinckx, Marcus Kilpatrick, Omid Omidvar, Gregory Bonomo, Mary Freeman, Jessica Shaw, Jessica Streit, Robert DeJager
4:06 p.m.
S17.004
4:18 p.m.
S17.005
Exome Sequencing Offers a Comprehensive Genetic Evaluation and High Diagnostic Rate for Ataxia-related Disorders —Francisca Millan, Dianalee McKnight, Julie Scuffins, Jane Juusola, Gabriele Richard, Amanda Lindy EPI-743 (Alpha-tocotrienol Quinone) Demonstrates Long-Term Improvement in Neurological Function and Disease Progression in Friedreich’s Ataxia —Theresa Zesiewicz, Susan Perlman, Kelly Sullivan, Yangxin Huang, Jason Salemi, Matthew Klein, Charles Isaacs, Clifton Gooch, Jessica Shaw, David Lynch
MONDAY
4:30 p.m.
S17.006
4:42 p.m.
S17.007
Cerebellar Pathology in Early Onset and Late Onset Essential Tremor —Sheng-Han Kuo, Jie Wang, William Tate, Ming-Kai Pan, Geoffrey Kelly, Jesus Gutierrez, Etty Cortes, Jean Paul Vonsattel, Elan Louis, Phyllis Faust Structure-Phenotype relationships in ATP1A3 (Na,K-ATPase) diseases —Kathleen Sweadner, Elena Arystarkhova, John Penniston, Jared Cook, Kathryn Swoboda, Allison Brashear, Laurie Ozelius
4:54 p.m.
S17.008
5:06 p.m.
Discussion
In vivo drug discovery for progressive supranuclear palsy using a novel zebrafish model —Qing Bai, Edward Burton
Neurology
Behavioral Neurology Sponsored by the American Academy of Neurology and endowed through Dr. Geschwind’s family, friends, and colleagues; Pfizer Inc; and the Society for Behavioral and Cognitive Neurology.
Recipient:
Peter Turkeltaub, MD, PhD Washington, DC
3:42 p.m. Alliance Awards:
S. Weir Mitchell Sponsored by the American Academy of Neurology and endowed by the former American Academy of Neurology Alliance.
Recipient:
Richard Ryan Darby, MD Boston, MA
3:54 p.m.
S18.003
Do We Practice What We Preach Regarding Clinical Cognitive Testing: Results From an AAN Behavioral Neurology Section Survey —James Bateman, Kirk Daffner, Seth Gale, A. Barrett, Bradley Boeve, Glen Finney, Darren Gitelman, John Hart, Alan Lerner, Kimford Meador, Mary Quiceno, Kytja Voeller, Valerie Whitney, Daniel Kaufer
4:06 p.m.
S18.004
Hippocampal and white matter hyperintensity volumes are associated with domain-specific cognitive decline: the Northern Manhattan Study —Michelle Caunca, Chuanhui Dong, Chensy Marquez, Ken Cheung, Tatjana Rundek, Noam Alperin, Ahmet Bagci, Mitchell Elkind, Charles DeCarli, Sang Lee, Ralph Sacco, Yaakov Stern, Clinton Wright
4:18 p.m.
S18.005
4:30 p.m.
S18.006
Systems-level network integration predicts TMS effects on time perception —Rachel Wurzman, Martin Wiener, Roy Hamilton, H. Coslett, John Medaglia Relative preservation of affect recognition in posterior cortical atrophy —Peter Pressman, Kelly Gola, Suzie Shdo, Bruce Miller, Katherine Rankin
4:42 p.m.
S18.007
Dysmetria of Thought and the Universal Cerebellar Transform: empirical evidence, future approaches, and relevance for embodied cognition. —Xavier Guell, Mark Halko, Faranak Farzan, Catherine Stoodley, Alvaro Pascual-Leone, John Gabrieli, Jeremy Schmahmann
4:54 p.m.
S18.008
Cingulo-Insular Structural Alterations Associated with Psychogenic Symptoms, Childhood Abuse and PTSD in Functional Neurological Disorders —David Perez, Nassim Matin, Arthur Barsky, Victor Costumero-Ramos, Sara Makaretz, Sigrid Young, Jorge Sepulcre, W. LaFrance, Matcheri Keshavan, Bradford Dickerson
5:06 p.m.
64 2017 AAN Annual Meeting Science Program
Discussion
Cerebrovascular Disease and Interventional Neurology
are listed in “Best of” Scientific Platform Sessions on page 48 »
and Other Autoimmune Disorders
Justification for New Diagnostic Criteria for Susac Syndrome: Evolving Beyond the Triad —Robert Carruthers, Gillian Paton, Claire Sheldon, Anthony Traboulsee, Mollie Carruthers, Robert Rennebohm Specificity of glial fibrillary acidic protein IgG autoantibody (GFAP-IgG) for Autoimmune Meningoencephalomyelitis Diagnosis — Eoin Flanagan, Divyanshu Dubey, Shannon Hinson, Vanda Lennon, Boyan Fang, Allen Aksamit, Brian Weinshenker, Sean Pittock, Andrew McKeon Pathophysiological impact of anti-AMPA receptor antibodies in autoimmune encephalitis —Holger Haselmann, Christian Werner, Benedikt Grünewald, Christian Geis IgLON5 Autoimmunity: Serological Findings, Neurological Disorders & Outcomes in 16 patients —Josephe Archie Honorat, Lars Komorowski, Erik St. Louis, Kai Fechner, Shannon Hinson, Sabine Lederer, Neeraj Kumar, Vanda Lennon, Sean Pittock, Andrew McKeon Aquaporin-4 serostatus does not predict response to immunotherapy in neuromyelitis optica spectrum disorders —Maureen Mealy, Su-Hyun Kim, Felix Schmidt, Reydmar Lopez, Jorge Jimenez Arango, Friedemann Paul, Dean Wingerchuk, Benjamin Greenberg, Ho Jin Kim, Michael Levy Placental transmission of AQP4-IgG to neonate from mothers with neuromyelitis optica spectrum disorder (NMOSD) — Jessica Sagen, Masoud Majed, Vanda Lennon, Claudia Lucchinetti, James Fryer, Sean Pittock Aquaporin-4 antibody titration in NMO patients treated with Rituximab: a retrospective study. —Antonio Bertolotto, Marco Alfonso Narduc Capobianco, Letizia Granieri, Fabiana Marnetto, Paola Valentino Central Dysregulation of Heart Rate and Blood Pressure in Autoimmune AQP4 Channelopathy: Expanding the neuromyelitis optica spectrum disorder (NMOSD). — Masoud Majed, Eduardo Benarroch, Claudia Lucchinetti, Karl Krecke, Jessica Sagen, Yong Guo, Chiara Costanzi, Sean Pittock